January M. Weiner
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
CD31+ Cell Enrichment Enhances Therapeutic Effects of Stromal Vascular Fraction in Experimental Primary Osteoarthritis: A Preclinical Study in the Dunkin Hartley Guinea Pig Model.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 02, 2025
Loss of Endothelial YAP/TAZ Reduces the Size of Chronic Stroke Lesions and Alters the Endothelial Environment.
Journal: Journal of the American Heart Association
Published: November 26, 2025
The MagMa Study: Quantum Magnetocardiography in Cardiomyopathy.
Journal: JACC. Heart failure
Published: October 15, 2025
Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE.
Journal: Biomedicines
Published: August 12, 2025
Non-hematopoietic erythropoietin splice variant is produced in the diseased human brain and confers neuroprotection.
Journal: Frontiers in cellular neuroscience
Published: July 31, 2025
Cytokine-associated ROS and Ca2+ dysregulation in severe inflammatory cardiomyopathy.
Journal: Cardiovascular research
Published: July 01, 2025
Sputum host cytokine signatures for diagnosis of TB in children and adults.
Journal: Frontiers in immunology
Published: June 24, 2025
Unveiling tissue-specific transcriptional adaptations in iPSC-derived fibroblasts via co-culture systems.
Journal: Stem cell research & therapy
Published: April 16, 2025
Lung tissue-optimized gene editing in human cystic fibrosis models following topical application of lipid nanoparticles.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 07, 2025
Molecular screening in a translational large animal trial identifies a differential inflammatory response for MINOCA.
Journal: Basic research in cardiology
Published: December 16, 2024
Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases.
Journal: EMBO molecular medicine
Published: November 07, 2024
Last Updated: 09/26/2026